Gossage

Goose Gossage really shouldn’t be disparaging Mariano Rivera

62 Comments

Over the weekend Goose Gossage — while prefacing every statement with the caveat that he was not taking anything away from Mariano Rivera — said a lot of stuff that pretty clearly suggested that he was taking things away from Mariano Rivera.  The upshot: he’s a good one inning closer, that Mo, but back in my day we closed out games for three innings. Uphill. Both ways.

Which, yes, there is truth to the notion that relievers of the 70s and into the 80s were used very differently than they are today. And, in my view, I think a lot of these guys such as John Hiller, Dan Quisenberry and even Gossage to some degree are undersold.

But go read what Joe Posnanski wrote on the topic yesterday before you give Gossage his due for telling the one-inning closers to get off his lawn.  Specifically: (a) that for as much as Gossage wants to play up his iron man credentials, he really was done with that kind of work in the first half of his career and spent the second half being used much more like a modern closer; and (b) no matter what you can say about the usage patterns, it is undeniable that Rivera has been far, far better a pitcher in his career than Gossage was in his.

This shouldn’t be debatable. Mariano Rivera was the best of all time, in my view. He is of the same kind as the modern closer, but he is in such a different class than his peers that it’s comical.

As is most of what Gossage says these days about pretty much everything, but you didn’t need me to tell you that.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.